Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Six people, including four Pakistani men, charged in $41M insider trading scheme using fake drug data and merger secrets to manipulate pharma stocks.
Six people, including four men of Pakistani origin, have been charged in a $41 million insider trading and market manipulation scheme targeting pharmaceutical companies developing cancer and opioid overdose treatments.
The fraud, active from 2020 to 2024, involved stolen non-public information, falsified clinical data, and fake press releases to inflate stock prices.
Prosecutors allege the group generated illicit profits by trading on confidential merger details and fabricating drug trial results, including a nearly 30% stock surge for one company.
The defendants face multiple federal charges with potential prison sentences of up to 25 years.
Seis personas, incluidos cuatro hombres paquistaníes, acusados en un esquema de intercambio de información privilegiada de $41 millones utilizando datos falsos de medicamentos y secretos de fusión para manipular las acciones farmacéuticas.